MX2020003661A - Formas de dosificacion de liquidos, metodos de fabricacion y uso. - Google Patents

Formas de dosificacion de liquidos, metodos de fabricacion y uso.

Info

Publication number
MX2020003661A
MX2020003661A MX2020003661A MX2020003661A MX2020003661A MX 2020003661 A MX2020003661 A MX 2020003661A MX 2020003661 A MX2020003661 A MX 2020003661A MX 2020003661 A MX2020003661 A MX 2020003661A MX 2020003661 A MX2020003661 A MX 2020003661A
Authority
MX
Mexico
Prior art keywords
dosage forms
manufacturing methods
liquid dosage
methods
cannabis
Prior art date
Application number
MX2020003661A
Other languages
English (en)
Inventor
Ben Geiling
Tom Shipley
Original Assignee
Canopy Growth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canopy Growth Corp filed Critical Canopy Growth Corp
Publication of MX2020003661A publication Critical patent/MX2020003661A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

En el presente documento se describen formulaciones de cannabis y derivados de cannabis, métodos de fabricación y métodos de uso de la formulación en formas de dosificación oral, preferentemente en formas de bebidas.
MX2020003661A 2017-11-30 2018-11-30 Formas de dosificacion de liquidos, metodos de fabricacion y uso. MX2020003661A (es)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201762592993P 2017-11-30 2017-11-30
US201762611851P 2017-12-29 2017-12-29
US201862618790P 2018-01-18 2018-01-18
US201862632309P 2018-02-19 2018-02-19
US201862632279P 2018-02-19 2018-02-19
US201862632286P 2018-02-19 2018-02-19
US201862632272P 2018-02-19 2018-02-19
US201862632299P 2018-02-19 2018-02-19
US201862632289P 2018-02-19 2018-02-19
US201862632295P 2018-02-19 2018-02-19
PCT/CA2018/051533 WO2019104442A1 (en) 2017-11-30 2018-11-30 Liquid dosage forms, methods of making and use

Publications (1)

Publication Number Publication Date
MX2020003661A true MX2020003661A (es) 2020-08-03

Family

ID=66664256

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020003661A MX2020003661A (es) 2017-11-30 2018-11-30 Formas de dosificacion de liquidos, metodos de fabricacion y uso.

Country Status (7)

Country Link
US (1) US20200289459A1 (es)
EP (1) EP3716945A4 (es)
AU (1) AU2018377175A1 (es)
CA (1) CA3076963C (es)
IL (1) IL273706A (es)
MX (1) MX2020003661A (es)
WO (1) WO2019104442A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019251357B2 (en) 2018-04-09 2023-10-05 Portland Technology Holdings Llc Hemp extract for treatment of pain in animals
AU2019285379A1 (en) * 2018-06-15 2021-02-04 CannPal Animal Therapeutics Limited Cannabinoid composition and methods of treatment using the same
MX2021002050A (es) * 2018-08-20 2021-07-15 Hexo Operations Inc Producto infundido con cannabis con experiencia de usuario de perfil de cannabinoides potenciado.
WO2020044116A1 (en) * 2018-08-27 2020-03-05 Emerald Health Therapeutics Canada Inc. Therapeutic combinations of cannabinoids with curcumin
WO2020146478A1 (en) * 2019-01-08 2020-07-16 Replennabis LLC Cannabinoid formulations for treating alcohol hangover
WO2020214569A1 (en) 2019-04-15 2020-10-22 Metagenics, Inc. Novel hemp and pea formulation and its use
US11554098B2 (en) 2019-05-03 2023-01-17 HFL Partners, LLC Compositions comprising molecularly separated cannabinoids and terpene blends and methods of producing
CN114727970A (zh) * 2019-07-02 2022-07-08 艾乐文特科学公司 用于治疗动物中的疼痛、癌症和癫痫的大麻提取物
US12557843B2 (en) * 2019-07-15 2026-02-24 Raymond Louis Larson Other than cannabinoids, flavonoids, and terpenes
US20210169795A1 (en) * 2019-12-06 2021-06-10 Joshua Steindler Colloidal Suspensions of Plant Extracts in Aqueous Solutions
AU2020401471A1 (en) * 2019-12-09 2022-07-07 Nicoventures Trading Limited Oral product comprising a cannabinoid
SMT202300032T1 (it) * 2020-01-06 2023-03-17 Cannaxan Gmbh Preparazione ed uso di nano-formulazione di cannabis
CN113087599A (zh) * 2020-01-08 2021-07-09 成都百裕制药股份有限公司 大麻二酚衍生物及其制备方法和在医药上的应用
WO2021139739A1 (zh) 2020-01-08 2021-07-15 成都百裕制药股份有限公司 大麻二酚衍生物及其制备方法和在医药上的应用
US20210267907A1 (en) * 2020-02-27 2021-09-02 Prinova Flavors LLC Water-soluble microencapsulated cannabinoid extract powder and method of making the same
EP4125834A4 (en) * 2020-03-30 2024-05-08 Ojai Energetics PBC SYSTEMS, METHODS AND COMPOSITIONS FOR INFECTIONS
WO2021198985A1 (en) * 2020-04-02 2021-10-07 Brown, Brian Tetrahydrocannabinol emulsion and method of making and using
US12138241B2 (en) * 2020-07-08 2024-11-12 Shaman Naturals, Llc Compositions for preventing and treating diabetes
AU2020481908A1 (en) * 2020-12-16 2023-06-29 TARK, Hye Ryun Method for preparing vegetable oil emulsion using cannabidiol oil
EP4277618A4 (en) * 2021-01-18 2024-12-04 Hadasit Medical Research Services & Development Company, Ltd. COMPOSITIONS AND METHODS FOR THE TREATMENT OF BLADDER DISEASES
JP7776723B2 (ja) 2021-03-25 2025-11-27 日亜化学工業株式会社 収穫後植物の処理方法及び処理装置
JP2024528847A (ja) * 2021-07-22 2024-08-01 ニコベンチャーズ トレーディング リミテッド カンナビノイド及び／又はカンナビノイド類似体を含むナノエマルジョン
US12440454B2 (en) 2022-02-01 2025-10-14 Portland Technology Holdings Llc Pharmaceutical compositions containing hemp extract for administration to felines and related methods
US11666544B1 (en) * 2022-07-05 2023-06-06 Poviva Corp. Compositions and methods for treating hypertension
WO2024173839A1 (en) * 2023-02-16 2024-08-22 The Coca-Cola Company Emulsions with water insoluble functional ingredients
WO2025024862A1 (en) * 2023-07-27 2025-01-30 Defloria Llc Composition of cannabinoid extract of cw1as1 for the treatment of autism and associated symptoms
KR20250072048A (ko) * 2023-11-16 2025-05-23 윤병인 항당뇨용 차바테 음료 조성물 및 이의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
ATE533472T1 (de) * 2002-08-14 2011-12-15 Gw Pharma Ltd Flüssige cannabinoid-formulierungen zur verabreichung an die schleimhäute
WO2009133573A2 (en) * 2008-04-29 2009-11-05 Gunvant Devichand Oswal A homeopathic formulation
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US10028919B2 (en) * 2015-03-10 2018-07-24 Nanosphere Health Sciences, Llc Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
AU2016231788A1 (en) * 2015-03-19 2017-10-12 One World Cannabis Ltd Preparations of cannabis emulsions and methods thereof
CA3021144C (en) * 2016-04-19 2024-04-09 Canabuzz-Med Cannabis-enriched enzymatically treated therapeutic composition
EP3582755A4 (en) * 2017-02-15 2020-12-23 Molecular Infusions, LLC PREPARATIONS
CN107348282A (zh) * 2017-08-18 2017-11-17 黑龙江省科学院大庆分院 汉麻叶功能饮料及其制备方法

Also Published As

Publication number Publication date
EP3716945A1 (en) 2020-10-07
IL273706A (en) 2020-05-31
AU2018377175A1 (en) 2020-04-16
WO2019104442A1 (en) 2019-06-06
EP3716945A4 (en) 2021-04-07
US20200289459A1 (en) 2020-09-17
CA3076963C (en) 2022-03-29
CA3076963A1 (en) 2019-06-06

Similar Documents

Publication Publication Date Title
MX2020003661A (es) Formas de dosificacion de liquidos, metodos de fabricacion y uso.
CO2019012353A2 (es) Formulaciones de anticuerpos anti-lag3 y coformulaciones de anticuerpos anti-lag3 y anticuerpos anti-pd-1
CL2019000793A1 (es) Moduladores de calpaínas y usos terapéuticos de los mismos.
CL2019000477A1 (es) Un esteroide 19 nor-c21-n-pirazolilo c3,3- disustituido cristalino.
MX379193B (es) Composiciones en solucion solida y su uso en inflamacion cronica.
CL2016002269A1 (es) Moduladores alostéricos del núcleo proteico de la hepatitis b.
MX421186B (es) Constructos de anticuerpos.
CL2015002304A1 (es) Formas del metil {4,6-diamino-2- [1- (2-fluorobencil)-1h-pirazolo [3,4-b] piridino-3-il] pirimidino-5-il} metil carbamato
ECSP18060848A (es) Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espiro-[ 4.5]-decano
CL2023002539A1 (es) Formas de dosificación pediátricas de vitamina d, métodos de elaboración y uso
ECSP18060820A (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano
BR112017003219A2 (pt) formulação de acetato de abiraterona e métodos de uso
ECSP18060875A (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano
CL2018001911A1 (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano
ECSP18060864A (es) Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano
MX389026B (es) Una composicion farmaceutica y el uso de la misma.
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
MX2018005350A (es) Formulacion de combinacion de dosis fija, eflornitina y sulindaco.
CR20160369A (es) Composiciones para uso en el tratamiento de afecciones alérgicas
EA201991319A1 (ru) Вакцины аттенуированного свиного гриппа и способы их изготовления и применения
CO2019010605A2 (es) Material mixto de caucho y procedimiento para obtener el mismo campo tecnológico
PH12018502139A1 (en) Phosphaplatin liquid formulations
MX2017007596A (es) Procedimiento para fabricar partículas de resinato de fenilefrina; partículas de resinato de fenilefrina; y uso de las partículas de resinato de fenilefrina en formulaciones farmacéuticas.
MX2020004105A (es) Formulacion farmaceutica.
EP3662902C0 (en) FORMULATION FOR THE RELEASE OF DRUGS IN THE COLON